European Patent Office

T 0406/17 (Composition with a botulinum neurotoxin / MERZ PHARMA) of 21.10.2021

European Case Law Identifier
ECLI:EP:BA:2021:T040617.20211021
Date of decision
21 October 2021
Case number
T 0406/17
Online on
8 November 2021
Petition for review of
-
Application number
05765454.3
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
THERAPEUTIC COMPOSITION WHIT A BOTULINUM NEUROTOXIN
Applicant name
Merz Pharma GmbH & Co. KGaA
Opponent name
ALLERGAN, INC.
Board
3.3.07
Headnote
-
Relevant legal provisions
Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 25(1) (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)European Patent Convention Art 100(c) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 111(1) (2007)
Keywords
Amendments - extension beyond the content of the application as filed (no)
Remittal - special reasons for remittal
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The decision under appeal is set aside. The case is remitted to the opposition division for further prosecution.